Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 1/2013

01.01.2013

Long-term outcomes (>2 years) of atrial fibrillation ablation using a multi-electrode ablation catheter in patients with paroxysmal atrial fibrillation

verfasst von: Khang-Li Looi, Parag Gajendragadkar, Tamer Taha, Maros Elsik, Elizabeth Scully, Patrick Heck, Simon Fynn, Munmohan Virdee, David Begley

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Catheter ablation for paroxysmal atrial fibrillation (PAF) is an effective treatment. Favourable outcomes at 6–12 months post-ablation have been reported using the multi-electrode catheter ‘pulmonary vein ablation catheter (PVAC)’ but little is known about longer term outcomes. There are also limited data on quality of life (QoL) post-atrial fibrillation (AF) ablation beyond 2 years of follow-up.

Methods

Two hundred three consecutive patients (77 % male, mean age 57.7 ± 11 years) who had a PAF ablation were included. Patients underwent conventional pulmonary vein isolation (PVI) (n = 128) or PVAC ablation (n = 75). Patients' symptoms were scored at baseline, at clinic follow-up and on questionnaire follow-up using the validated Canadian Cardiovascular Society Severity of AF (CCS-SAF) scale. The ‘AF Effect on QualiTy of life’ (AFEQT) questionnaire was used on questionnaire follow-up.

Results

Mean questionnaire follow-up was 854 ± 176 days with 74 % response rate. The majority of patients (91.6 % overall) were highly symptomatic at baseline with CCS-SAF class 3 or 4 symptoms. CCS-SAF class on follow-up questionnaire decreased significantly from baseline for both groups (mean 1.69 ± 1.7 for PVAC and 1.45 ± 1.5 for PVI, p = 0.001 and p < 0.001, respectively) with no difference between groups (p = 0.52) and the majority being class 0 or 1 (59.9 % overall). Mean AFEQT questionnaire scores were similar between both groups (78.1 ± 25 vs. 82 ± 23, p = 0.35). Total procedure time was significantly shorter in the PVAC group (135 ± 54 vs. 178 ± 43 min, p < 0.001).

Conclusion

There was a comparable and significant improvement in QoL post-ablation in patients who underwent ablation using PVAC catheter and conventional techniques.
Literatur
2.
Zurück zum Zitat Cappato, R., Calkins, H., Chen, S.-A., Davies, W., Iesaka, Y., Kalman, J., et al. (2010). Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation/clinical perspective. Circulation. Arrhythmia and Electrophysiology, 3(1), 32–38. doi:10.1161/circep.109.859116.PubMedCrossRef Cappato, R., Calkins, H., Chen, S.-A., Davies, W., Iesaka, Y., Kalman, J., et al. (2010). Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation/clinical perspective. Circulation. Arrhythmia and Electrophysiology, 3(1), 32–38. doi:10.​1161/​circep.​109.​859116.PubMedCrossRef
3.
Zurück zum Zitat Boersma, L. V. A., Wijffels, M. C. E. F., Oral, H., Wever, E. F. D., & Morady, F. (2008). Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a multielectrode ablation catheter. Heart Rhythm, 5(12), 1635–1642.PubMedCrossRef Boersma, L. V. A., Wijffels, M. C. E. F., Oral, H., Wever, E. F. D., & Morady, F. (2008). Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a multielectrode ablation catheter. Heart Rhythm, 5(12), 1635–1642.PubMedCrossRef
4.
Zurück zum Zitat Fredersdorf, S., Weber, S., Jilek, C., Heinicke, N., Von Bary, C., Jungbauer, C., et al. (2009). Safe and rapid isolation of pulmonary veins using a novel circular ablation catheter and duty-cycled RF generator. Journal of Cardiovascular Electrophysiology, 20(10), 1097–1101. doi:10.1111/j.1540-8167.2009.01501.x.PubMedCrossRef Fredersdorf, S., Weber, S., Jilek, C., Heinicke, N., Von Bary, C., Jungbauer, C., et al. (2009). Safe and rapid isolation of pulmonary veins using a novel circular ablation catheter and duty-cycled RF generator. Journal of Cardiovascular Electrophysiology, 20(10), 1097–1101. doi:10.​1111/​j.​1540-8167.​2009.​01501.​x.PubMedCrossRef
5.
Zurück zum Zitat Wieczorek, M., Hoeltgen, R., Brueck, M., Bandorski, D., Akin, E., & Reza Salili, A. (2010). Pulmonary vein isolation by duty-cycled bipolar and unipolar antrum ablation using a novel multielectrode ablation catheter system: first clinical results. Journal of Interventional Cardiac Electrophysiology, 27(1), 23–31. doi:10.1007/s10840-009-9446-z.PubMedCrossRef Wieczorek, M., Hoeltgen, R., Brueck, M., Bandorski, D., Akin, E., & Reza Salili, A. (2010). Pulmonary vein isolation by duty-cycled bipolar and unipolar antrum ablation using a novel multielectrode ablation catheter system: first clinical results. Journal of Interventional Cardiac Electrophysiology, 27(1), 23–31. doi:10.​1007/​s10840-009-9446-z.PubMedCrossRef
6.
Zurück zum Zitat Wieczorek, M., Hoeltgen, R., Akin, E., Salili, A. R., Oral, H., & Morady, F. (2010). Results of short-term and long-term pulmonary vein isolation for paroxysmal atrial fibrillation using duty-cycled bipolar and unipolar radiofrequency energy. Journal of Cardiovascular Electrophysiology, 21(4), 399–405. doi:10.1111/j.1540-8167.2009.01640.x.PubMedCrossRef Wieczorek, M., Hoeltgen, R., Akin, E., Salili, A. R., Oral, H., & Morady, F. (2010). Results of short-term and long-term pulmonary vein isolation for paroxysmal atrial fibrillation using duty-cycled bipolar and unipolar radiofrequency energy. Journal of Cardiovascular Electrophysiology, 21(4), 399–405. doi:10.​1111/​j.​1540-8167.​2009.​01640.​x.PubMedCrossRef
7.
Zurück zum Zitat Bulava, A., HaniŠ, J., Sitek, D., OŠMera, O., Karpianus, D. A. N., ŠNorek, M., et al. (2010). Catheter ablation for paroxysmal atrial fibrillation: a randomized comparison between multielectrode catheter and point-by-point ablation. Pacing and Clinical Electrophysiology, 33(9), 1039–1046. doi:10.1111/j.1540-8159.2010.02807.x.PubMedCrossRef Bulava, A., HaniŠ, J., Sitek, D., OŠMera, O., Karpianus, D. A. N., ŠNorek, M., et al. (2010). Catheter ablation for paroxysmal atrial fibrillation: a randomized comparison between multielectrode catheter and point-by-point ablation. Pacing and Clinical Electrophysiology, 33(9), 1039–1046. doi:10.​1111/​j.​1540-8159.​2010.​02807.​x.PubMedCrossRef
10.
Zurück zum Zitat Dorian, P., Guerra, P. G., Kerr, C. R., O’Donnell, S. S., Crystal, E., Gillis, A. M., et al. (2009). Validation of a new simple scale to measure symptoms in atrial fibrillation/clinical perspective. Circulation. Arrhythmia and Electrophysiology, 2(3), 218–224. doi:10.1161/circep.108.812347.PubMedCrossRef Dorian, P., Guerra, P. G., Kerr, C. R., O’Donnell, S. S., Crystal, E., Gillis, A. M., et al. (2009). Validation of a new simple scale to measure symptoms in atrial fibrillation/clinical perspective. Circulation. Arrhythmia and Electrophysiology, 2(3), 218–224. doi:10.​1161/​circep.​108.​812347.PubMedCrossRef
11.
Zurück zum Zitat Spertus, J., Dorian, P., Bubien, R., Lewis, S., Godejohn, D., Reynolds, M. R., et al. (2011). Development and validation of the atrial fibrillation effect on quality-of-life (AFEQT) questionnaire in patients with atrial fibrillation/clinical perspective. Circulation. Arrhythmia and Electrophysiology, 4(1), 15–25. doi:10.1161/circep.110.958033.PubMedCrossRef Spertus, J., Dorian, P., Bubien, R., Lewis, S., Godejohn, D., Reynolds, M. R., et al. (2011). Development and validation of the atrial fibrillation effect on quality-of-life (AFEQT) questionnaire in patients with atrial fibrillation/clinical perspective. Circulation. Arrhythmia and Electrophysiology, 4(1), 15–25. doi:10.​1161/​circep.​110.​958033.PubMedCrossRef
12.
Zurück zum Zitat Dorian, P., Jung, W., Newman, D., Paquette, M., Wood, K., Ayers, G. M., et al. (2000). The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. Journal of the American College of Cardiology, 36(4), 1303–1309. doi:10.1016/s0735-1097(00)00886-x.PubMedCrossRef Dorian, P., Jung, W., Newman, D., Paquette, M., Wood, K., Ayers, G. M., et al. (2000). The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. Journal of the American College of Cardiology, 36(4), 1303–1309. doi:10.​1016/​s0735-1097(00)00886-x.PubMedCrossRef
15.
Zurück zum Zitat Clark, D. M., Plumb, V. J., Epstein, A. E., & Kay, G. N. (1997). Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. Journal of the American College of Cardiology, 30(4), 1039–1045.PubMedCrossRef Clark, D. M., Plumb, V. J., Epstein, A. E., & Kay, G. N. (1997). Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. Journal of the American College of Cardiology, 30(4), 1039–1045.PubMedCrossRef
16.
Zurück zum Zitat Carlsson, J., Miketic, S., Windeler, J., Cuneo, A., Haun, S., Micus, S., et al. (2003). Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. Journal of the American College of Cardiology, 41(10), 1690–1696. doi:10.1016/s0735-1097(03)00332-2.PubMedCrossRef Carlsson, J., Miketic, S., Windeler, J., Cuneo, A., Haun, S., Micus, S., et al. (2003). Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. Journal of the American College of Cardiology, 41(10), 1690–1696. doi:10.​1016/​s0735-1097(03)00332-2.PubMedCrossRef
17.
Zurück zum Zitat Van Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., et al. (2002). A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. The New England Journal of Medicine, 347(23), 1834–1840. doi:10.1056/NEJMoa021375347/23/1834.PubMedCrossRef Van Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., et al. (2002). A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. The New England Journal of Medicine, 347(23), 1834–1840. doi:10.​1056/​NEJMoa021375347/​23/​1834.PubMedCrossRef
18.
Zurück zum Zitat Wyse, D. G., Waldo, A. L., DiMarco, J. P., Domanski, M. J., Rosenberg, Y., Schron, E. B., et al. (2005). Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. American Heart Journal, 149(1), 112–120. doi:10.1016/j.ahj.2004.03.065.CrossRef Wyse, D. G., Waldo, A. L., DiMarco, J. P., Domanski, M. J., Rosenberg, Y., Schron, E. B., et al. (2005). Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. American Heart Journal, 149(1), 112–120. doi:10.​1016/​j.​ahj.​2004.​03.​065.CrossRef
19.
Zurück zum Zitat Jenkins, L. S., Brodsky, M., Schron, E., Chung, M., Rocco, T., Jr., Lader, E., et al. (2005). Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. American Heart Journal, 149(1), 112–120. doi:10.1016/j.ahj.2004.03.065.PubMedCrossRef Jenkins, L. S., Brodsky, M., Schron, E., Chung, M., Rocco, T., Jr., Lader, E., et al. (2005). Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. American Heart Journal, 149(1), 112–120. doi:10.​1016/​j.​ahj.​2004.​03.​065.PubMedCrossRef
20.
Zurück zum Zitat Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S. A., et al. (2012). HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace, 14(4), 528–606. doi:10.1093/europace/eus027.PubMedCrossRef Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S. A., et al. (2012). HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace, 14(4), 528–606. doi:10.​1093/​europace/​eus027.PubMedCrossRef
21.
Zurück zum Zitat Tada, H., Naito, S., Kurosaki, K., Ueda, M., Ito, S., Shinbo, G., et al. (2003). Segmental pulmonary vein isolation for paroxysmal atrial fibrillation improves quality of life and clinical outcomes. Circulation Journal, 67(10), 861–865.PubMedCrossRef Tada, H., Naito, S., Kurosaki, K., Ueda, M., Ito, S., Shinbo, G., et al. (2003). Segmental pulmonary vein isolation for paroxysmal atrial fibrillation improves quality of life and clinical outcomes. Circulation Journal, 67(10), 861–865.PubMedCrossRef
22.
Zurück zum Zitat Pappone, C., Rosanio, S., Augello, G., Gallus, G., Vicedomini, G., Mazzone, P., et al. (2003). Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. Journal of the American College of Cardiology, 42(2), 185–197.PubMedCrossRef Pappone, C., Rosanio, S., Augello, G., Gallus, G., Vicedomini, G., Mazzone, P., et al. (2003). Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. Journal of the American College of Cardiology, 42(2), 185–197.PubMedCrossRef
23.
Zurück zum Zitat Tse, H.-F., Sin, P.-Y., Siu, C.-W., Tsang, V., Lam, C. L. K., & Lau, C.-P. (2005). Successful pulmonary vein isolation using transvenous catheter cryoablation improves quality-of-life in patients with atrial fibrillation. Pacing and Clinical Electrophysiology, 28(5), 421–424. doi:10.1111/j.1540-8159.2005.50001.x.PubMedCrossRef Tse, H.-F., Sin, P.-Y., Siu, C.-W., Tsang, V., Lam, C. L. K., & Lau, C.-P. (2005). Successful pulmonary vein isolation using transvenous catheter cryoablation improves quality-of-life in patients with atrial fibrillation. Pacing and Clinical Electrophysiology, 28(5), 421–424. doi:10.​1111/​j.​1540-8159.​2005.​50001.​x.PubMedCrossRef
24.
Zurück zum Zitat Miyazaki, S., Kuwahara, T., Takahashi, A., Kobori, A., Takahashi, Y., Nozato, T., et al. (2007). Effect of left atrial ablation on the quality of life in patients with atrial fibrillation. Circulation Journal, 72(4), 582–587.CrossRef Miyazaki, S., Kuwahara, T., Takahashi, A., Kobori, A., Takahashi, Y., Nozato, T., et al. (2007). Effect of left atrial ablation on the quality of life in patients with atrial fibrillation. Circulation Journal, 72(4), 582–587.CrossRef
26.
Zurück zum Zitat Fichtner, S., Deisenhofer, I., KindsmÜLler, S., Dzijan-Horn, M., Tzeis, S., Reents, T., et al. (2012). Prospective assessment of short- and long-term quality of life after ablation for atrial fibrillation. Journal of Cardiovascular Electrophysiology, 23(2), 121–127. doi:10.1111/j.1540-8167.2011.02165.x.PubMedCrossRef Fichtner, S., Deisenhofer, I., KindsmÜLler, S., Dzijan-Horn, M., Tzeis, S., Reents, T., et al. (2012). Prospective assessment of short- and long-term quality of life after ablation for atrial fibrillation. Journal of Cardiovascular Electrophysiology, 23(2), 121–127. doi:10.​1111/​j.​1540-8167.​2011.​02165.​x.PubMedCrossRef
27.
Zurück zum Zitat Bubien, R. S., Knotts-Dolson, S. M., Plumb, V. J., & Kay, G. N. (1996). Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation, 94(7), 1585–1591. doi:10.1161/01.cir.94.7.1585.PubMedCrossRef Bubien, R. S., Knotts-Dolson, S. M., Plumb, V. J., & Kay, G. N. (1996). Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation, 94(7), 1585–1591. doi:10.​1161/​01.​cir.​94.​7.​1585.PubMedCrossRef
29.
Zurück zum Zitat Wokhlu, A., Monahan, K. H., Hodge, D. O., Asirvatham, S. J., Friedman, P. A., Munger, T. M., et al. (2010). Long-term quality of life after ablation of atrial fibrillation: the impact of recurrence, symptom relief, and placebo effect. Journal of the American College of Cardiology, 55(21), 2308–2316. doi:10.1016/j.jacc.2010.01.040.PubMedCrossRef Wokhlu, A., Monahan, K. H., Hodge, D. O., Asirvatham, S. J., Friedman, P. A., Munger, T. M., et al. (2010). Long-term quality of life after ablation of atrial fibrillation: the impact of recurrence, symptom relief, and placebo effect. Journal of the American College of Cardiology, 55(21), 2308–2316. doi:10.​1016/​j.​jacc.​2010.​01.​040.PubMedCrossRef
30.
Zurück zum Zitat Gaita, F., Leclercq, J. F., Schumacher, B., Scaglione, M., Toso, E., Halimi, F., et al. (2011). Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon. Journal of Cardiovascular Electrophysiology, 22(9), 961–968. doi:10.1111/j.1540-8167.2011.02050.x.PubMedCrossRef Gaita, F., Leclercq, J. F., Schumacher, B., Scaglione, M., Toso, E., Halimi, F., et al. (2011). Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon. Journal of Cardiovascular Electrophysiology, 22(9), 961–968. doi:10.​1111/​j.​1540-8167.​2011.​02050.​x.PubMedCrossRef
31.
Zurück zum Zitat Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003). Silent brain infarcts and the risk of dementia and cognitive decline. The New England Journal of Medicine, 348(13), 1215–1222. doi:10.1056/NEJMoa022066.PubMedCrossRef Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003). Silent brain infarcts and the risk of dementia and cognitive decline. The New England Journal of Medicine, 348(13), 1215–1222. doi:10.​1056/​NEJMoa022066.PubMedCrossRef
32.
Zurück zum Zitat Marquine, M. J., Attix, D. K., Goldstein, L. B., Samsa, G. P., Payne, M. E., Chelune, G. J., et al. (2010). Differential patterns of cognitive decline in anterior and posterior white matter hyperintensity progression. Stroke, 41(9), 1946–1950. doi:10.1161/strokeaha.110.587717.PubMedCrossRef Marquine, M. J., Attix, D. K., Goldstein, L. B., Samsa, G. P., Payne, M. E., Chelune, G. J., et al. (2010). Differential patterns of cognitive decline in anterior and posterior white matter hyperintensity progression. Stroke, 41(9), 1946–1950. doi:10.​1161/​strokeaha.​110.​587717.PubMedCrossRef
33.
Zurück zum Zitat Calkins, H., Brugada, J., Packer, D. L., Cappato, R., Chen, S.-A., Crijns, H. J. G., et al. (2007). HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for personnel, policy, procedures and follow-up. Europace, 9(6), 335–379. doi:10.1093/europace/eum120.PubMedCrossRef Calkins, H., Brugada, J., Packer, D. L., Cappato, R., Chen, S.-A., Crijns, H. J. G., et al. (2007). HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for personnel, policy, procedures and follow-up. Europace, 9(6), 335–379. doi:10.​1093/​europace/​eum120.PubMedCrossRef
34.
Zurück zum Zitat Calkins, H., Reynolds, M. R., Spector, P., Sondhi, M., Xu, Y., Martin, A., et al. (2009). Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation/clinical perspective. Circulation. Arrhythmia and Electrophysiology, 2(4), 349–361. doi:10.1161/circep.108.824789.PubMedCrossRef Calkins, H., Reynolds, M. R., Spector, P., Sondhi, M., Xu, Y., Martin, A., et al. (2009). Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation/clinical perspective. Circulation. Arrhythmia and Electrophysiology, 2(4), 349–361. doi:10.​1161/​circep.​108.​824789.PubMedCrossRef
35.
Zurück zum Zitat Schwarz, N., Kuniss, M., Nedelmann, M., Kaps, M., Bachmann, G., Neumann, T., et al. (2010). Neuropsychological decline after catheter ablation of atrial fibrillation. Heart Rhythm: the Official Journal of the Heart Rhythm Society, 7(12), 1761–1767.CrossRef Schwarz, N., Kuniss, M., Nedelmann, M., Kaps, M., Bachmann, G., Neumann, T., et al. (2010). Neuropsychological decline after catheter ablation of atrial fibrillation. Heart Rhythm: the Official Journal of the Heart Rhythm Society, 7(12), 1761–1767.CrossRef
36.
Zurück zum Zitat Bhargava, M., Di Biase, L., Mohanty, P., Prasad, S., Martin, D. O., Williams-Andrews, M., et al. (2009). Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study. Heart Rhythm, 6(10), 1403–1412.PubMedCrossRef Bhargava, M., Di Biase, L., Mohanty, P., Prasad, S., Martin, D. O., Williams-Andrews, M., et al. (2009). Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study. Heart Rhythm, 6(10), 1403–1412.PubMedCrossRef
37.
Zurück zum Zitat Hunter, R. J., Berriman, T. J., Diab, I., Baker, V., Finlay, M., Richmond, L., et al. (2010). Long-term efficacy of catheter ablation for atrial fibrillation: impact of additional targeting of fractionated electrograms. Heart, 96(17), 1372–1378. doi:10.1136/hrt.2009.188128.PubMedCrossRef Hunter, R. J., Berriman, T. J., Diab, I., Baker, V., Finlay, M., Richmond, L., et al. (2010). Long-term efficacy of catheter ablation for atrial fibrillation: impact of additional targeting of fractionated electrograms. Heart, 96(17), 1372–1378. doi:10.​1136/​hrt.​2009.​188128.PubMedCrossRef
38.
Zurück zum Zitat Bunch, T. J., Weiss, J. P., Crandall, B. G., May, H. T., Bair, T. L., Osborn, J. S., et al. (2010). Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Heart rhythm: The Official Journal of the Heart Rhythm Society, 7(4), 433–437.CrossRef Bunch, T. J., Weiss, J. P., Crandall, B. G., May, H. T., Bair, T. L., Osborn, J. S., et al. (2010). Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Heart rhythm: The Official Journal of the Heart Rhythm Society, 7(4), 433–437.CrossRef
39.
Zurück zum Zitat Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263–272. doi:10.1378/chest.09-1584.PubMedCrossRef Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263–272. doi:10.​1378/​chest.​09-1584.PubMedCrossRef
40.
Metadaten
Titel
Long-term outcomes (>2 years) of atrial fibrillation ablation using a multi-electrode ablation catheter in patients with paroxysmal atrial fibrillation
verfasst von
Khang-Li Looi
Parag Gajendragadkar
Tamer Taha
Maros Elsik
Elizabeth Scully
Patrick Heck
Simon Fynn
Munmohan Virdee
David Begley
Publikationsdatum
01.01.2013
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 1/2013
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-012-9744-8

Weitere Artikel der Ausgabe 1/2013

Journal of Interventional Cardiac Electrophysiology 1/2013 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.